FindTrial
Sign In

A comparative study of daily activities of patients of lumbar spondylosis between the individualised homoeopathic medicine and Zincum metallicum.

A comparative study on assessment of quality of life of patients of lumbar spondylosis with Zincum metallicum and individualized homoeopathic medicines. An open label, prospective non-randomised, pilot trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051293
Enrollment
30
Registered
2023-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

Intervention1: INDIVIDUALIZED HOMOEOPATHIC MEDICINE: IHM group: Intervention is planned as administering in centesimal potencies, as decided appropriate to the case or condition. In centesimal scale,
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition depending upon the individual requirement of the cases. Duration of therapy: 3 months.

Sponsors

Subhojit Das
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosed by x ray findings- diminution of the intervertebral spaces / inter articular joints are narrowed and irregular/ lipping at the corner of the vertebral bodies and presence of osteophytes around the interarticular joints. 2. Patients suffering from lumbar spondylosis at least of 3 months. 3. Literate persons: ability to read vernacular language 4. Providing written informed consent to participate.

Exclusion criteria

Exclusion criteria: 1. If patient suffering from any other chronic low back pain 2. Patients have undergone any organ transplantation 3. Patients using steroids/immunosuppressive medication/psychiatric disorders 4. Patients unwilling take part and not giving consent to join the study 5. Patients unable to read patient information sheet 6. Cases already undergoing homeopathic treatment for any chronic diseases 7. Cases suffering from uncontrolled systemic illness or life threatening infections.

Design outcomes

Primary

MeasureTime frame
The outcome will be assessed by using mymop 2.0 scale(and follow up) for quality of life, at base level and after 3 months.Timepoint: baseline and 3 months—

Secondary

MeasureTime frame
The comparative reduction of the pain will be assessed by using numerical rating pain scale (NRS scale) before and after treatment.Timepoint: baseline and 3 months—

Countries

India

Contacts

Public ContactDr Biswajit Bera

PRATAP CHANDRA MEMORIAL HOMOEOPATHIC HOSPITAL AND COLLEGE

berabiswajit721@gmail.com7797954454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026